Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 30, Issue 8, Pages 411-420Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2009.05.004
Keywords
-
Categories
Funding
- Intramural Research Program of the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism
- Hungarian Scientific Research Fund [63153]
Ask authors/readers for more resources
The newly discovered endocannabinoid system (ECS; comprising the endogenous lipid mediators endocannabinoids present in virtually all tissues, their G-protein-coupled cannabinoid receptors, biosynthetic pathways and metabolizing enzymes) has been implicated in multiple regulatory functions both in health and disease. Recent studies have intriguingly suggested the existence of a functional ECS in the skin and implicated it in various biological processes (e.g. proliferation, growth, differentiation, apoptosis and cytokine, mediator or hormone production of various cell types of the skin and appendages, such as the hair follicle and sebaceous gland). It seems that the main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and/or tolerance, of skin cells. The disruption of this delicate balance might facilitate the development of multiple pathological conditions and diseases of the skin (e.g. acne, seborrhea, allergic dermatitis, itch and pain, psoriasis, hair growth disorders, systemic sclerosis and cancer).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available